RECENT VIEWS ON MECHANISMS FOR LOWERING SYMPATHETIC TONE.
D000661:Amphetamine; D000662:Amphetamines; D000959:Antihypertensive Agents; D001669:Biochemical Phenomena; D001671:Biochemistry; D001949:Bretylium Compounds; D006145:Guanethidine; D006146:Guanidines; D006651:Histocytochemistry; D006801:Humans; D008660:Metabolism; D008680:Metaraminol; D008750:Methyldopa; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D009448:Neurochemistry; D009638:Norepinephrine; D012110:Reserpine; D013564:Sympathetic Nervous System
D000662:Amphetamines; D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D006146:Guanidines; D008996:Monoamine Oxidase Inhibitors; D008750:Methyldopa; D008680:Metaraminol; D012110:Reserpine; D000661:Amphetamine; D008995:Monoamine Oxidase; D009638:Norepinephrine; D006145:Guanethidine
AMPHETAMINE; ANTIHYPERTENSIVE AGENTS; BIOCHEMISTRY; BRETYLIUM COMPOUNDS; GUANETHIDINE; GUANIDINES; HISTOCYTOCHEMISTRY; METABOLISM; METARAMINOL; METHYLDOPA; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEUROCHEMISTRY; NOREPINEPHRINE; RESERPINE; REVIEW; SYMPATHETIC NERVOUS SYSTEM